Issues in Delivering Morbidity Management for Lymphatic Filariasis Elimination: a Study in Pondicherry, South India

Overview

Journal ScientificWorldJournal

Publisher Wiley

Specialty Biology

Date 2012 Jun 2

PMID 22654597

Citations 9

Authors

A Krishna Kumari

Yuvaraj J

L K Das

Affiliations

Soon will be listed here.

Abstract

Lymphatic filariasis is a vector borne parasitic disease causing long term disability. The Global Programme to Eliminate Lymphatic Filariasis aims to achieve its objective through two strategies; Mass Drug Administration (MDA) to interrupt transmission and Morbidity Management (MM) to manage disability for those already affected. MDA is going on in full swing in endemic areas; but MM is lagging behind. An exploratory study was conducted in Pondicherry through focus group discussions to find out whether there are delivery issues if any, in the MM programme and get suggestions from end users. The study results show that MM has not received the same attention as MDA and there are shortcomings in the delivery mechanism of the programme. The importance of these findings are discussed and suggestions given for improving the programme.

Citing Articles

Unveiling the gendered abyss: exploring the case of women with lymphatic filariasis and the path to inclusive care in India.

Rahul A, Choolayil A, Govindasamy D, Vijayalakshmi G, Anbusivam S, Kuttiatt V Int J Equity Health. 2025; 24(1):47.

PMID: 39962539 PMC: 11834584. DOI: 10.1186/s12939-025-02397-3.

Assessment of the Impact of Morbidity Management and Disability Prevention for Lymphatic Filariasis on the Disease Burden in Villupuram District of Tamil Nadu, India.

Mathiarasan L, Das L, Krishnakumari A Indian J Community Med. 2022; 46(4):657-661.

PMID: 35068729 PMC: 8729271. DOI: 10.4103/ijcm.IJCM_12_21.

Exploring determinants of hydrocele surgery coverage related to Lymphatic Filariasis in Nepal: An implementation research study.

Yonzon C, Padmawati R, Subedi R, Paudel S, Ghimire A, Murhandarwati E PLoS One. 2021; 16(2):e0244664.

PMID: 33635870 PMC: 7909642. DOI: 10.1371/journal.pone.0244664.

Health beliefs and health seeking behavior towards lymphatic filariasis morbidity management and disability prevention services in Luangwa District, Zambia: Community and provider perspectives.

Maritim P, Silumbwe A, Zulu J, Sichone G, Michelo C PLoS Negl Trop Dis. 2021; 15(2):e0009075.

PMID: 33617551 PMC: 7932505. DOI: 10.1371/journal.pntd.0009075.

The role of non-governmental development organizations in the implementation of lymphatic filariasis programmes.

Bush S, Richards F, Zhang Y Int Health. 2020; 13(Suppl 1):S44-S47.

PMID: 33349880 PMC: 7753161. DOI: 10.1093/inthealth/ihaa049.

References

Das P, Ramaiah K . Entomological monitoring of annual mass drug administrations for the control or elimination of lymphatic filariasis. Ann Trop Med Parasitol. 2003; 96 Suppl 2:S139-42. DOI: 10.1179/000349802125002491. View

Perera M, Whitehead M, Molyneux D, Weerasooriya M, Gunatilleke G . Neglected patients with a neglected disease? A qualitative study of lymphatic filariasis. PLoS Negl Trop Dis. 2007; 1(2):e128. PMC: 2100378. DOI: 10.1371/journal.pntd.0000128. View

Mukhopadhyay A . Lymphatic filariasis in Andhra Pradesh Paper Mill Colony, Rajahmundry, India after nine rounds of MDA programme. J Vector Borne Dis. 2010; 47(1):55-7. View

Lahariya C, Mishra A . Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. J Vector Borne Dis. 2009; 45(4):313-20. View

Pani S, Srividya A . Clinical manifestations of bancroftian filariasis with special reference to lymphoedema grading. Indian J Med Res. 1995; 102:114-8. View

Ramaiah K, Guyatt H, Ramu K, Vanamail P, Pani S, Das P . Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Trop Med Int Health. 1999; 4(1):19-25. DOI: 10.1046/j.1365-3156.1999.00351.x. View

Ottesen E, Duke B, Karam M, Behbehani K . Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ. 1997; 75(6):491-503. PMC: 2487030. View

Mathieu E, Amann J, Eigege A, Richards F, Sodahlon Y . Collecting baseline information for national morbidity alleviation programs: different methods to estimate lymphatic filariasis morbidity prevalence. Am J Trop Med Hyg. 2008; 78(1):153-8. View

Jullien P, Some J, Brantus P, Bougma R, Bamba I, Kyelem D . Efficacy of home-based lymphoedema management in reducing acute attacks in subjects with lymphatic filariasis in Burkina Faso. Acta Trop. 2011; 120 Suppl 1:S55-61. DOI: 10.1016/j.actatropica.2011.03.007. View

10.

Das P, Manoharan A, Subramanian S, Ramaiah K, Pani S, Rajavel A . Bancroftian filariasis in Pondicherry, south India--epidemiological impact of recovery of the vector population. Epidemiol Infect. 1992; 108(3):483-93. PMC: 2272216. DOI: 10.1017/s0950268800049992. View

11.

Yahathugoda T, Wickramasinghe D, Weerasooriya M, Samarawickrema W . Lymphoedema and its management in cases of lymphatic filariasis: the current situation in three suburbs of Matara, Sri Lanka, before the introduction of a morbidity-control programme. Ann Trop Med Parasitol. 2005; 99(5):501-10. DOI: 10.1179/136485905X46450. View

12.

Agrawal V, Sashindran V . Lymphatic Filariasis in India : Problems, Challenges and New Initiatives. Med J Armed Forces India. 2016; 62(4):359-62. PMC: 5034168. DOI: 10.1016/S0377-1237(06)80109-7. View

13.

Rath K, Swain B, Mishra S, Patasahani T, Kerketta A, Babu B . Peripheral health workers' knowledge and practices related to filarial lymphedema care: a study in an endemic district of Orissa, India. Am J Trop Med Hyg. 2005; 72(4):430-3. View

14.

Kerketta A, Babu B, Swain B . Clinicians' practices related to management of filarial adenolymphangitis and lymphoedema in Orissa, India. Acta Trop. 2007; 102(3):159-64. DOI: 10.1016/j.actatropica.2007.04.014. View

15.

Vaqas B, Ryan T . Lymphoedema: Pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programmes. Filaria J. 2003; 2(1):4. PMC: 153482. DOI: 10.1186/1475-2883-2-4. View